The SSO Executive Committee approved endorsing the ASTRO guideline on radiation therapy for soft tissue sarcoma in adults based on reviews done by members of the SSO’s Sarcoma Disease Site Work Group and Quality Committees. Read more at https://www.surgonc.org/2021/07/sso-endorses-new-astro-guideline-on-radiation-therapy-for-soft-tissue-sarcoma-in-adults/
SSO is pleased to comment on the National Cancer Institute RFIs, “Enhancing Diversity and Inclusion in the Cancer Research Workforce” and “Enhancing Cancer Health Disparities Research.” SSO comments were generated collaboratively by the Research Committee, Quality Committee, and Diversity-Inclusion Advisory Board and approved by SSO leadership. They identify challenges, strategies and ways to enhance diversity. Read the comments at https://www.surgonc.org/wp-content/uploads/2021/07/SSO-Comments-NCI-RFI-Cancer-Workforce-DI.pdf and https://www.surgonc.org/wp-content/uploads/2021/08/SSO-Comments-on-NCI-Cancer-Research-Disparities.pdf.